About Polfa Tarchomin
Polfa Tarchomin is a company based in Warsaw (Poland) founded in 1823. It operates as a B2B and B2C. Polfa Tarchomin offers products and services including Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and GOLDisept. Polfa Tarchomin operates in a competitive market with competitors including AmerisourceBergen, NEUCA, Pelion and Vitama, among others.
- Headquarter Warsaw, Poland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Tarchomińskie Zakłady Farmaceutyczne "Polfa" Spółka Akcyjna
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polfa Tarchomin
Polfa Tarchomin offers a comprehensive portfolio of products and services, including Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and GOLDisept.
Topical treatment for skin conditions and inflammation.
Medication for fungal infections in various forms.
Natural supplement for cholesterol management.
Probiotic blend for digestive health support.
Spray for throat relief and hygiene.
Moisturizing cream with protective ingredients.
People of Polfa Tarchomin
Unlock access to complete
Funding Insights of Polfa Tarchomin
Detailed funding history for Polfa Tarchomin
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polfa Tarchomin
Investment portfolio details for Polfa Tarchomin
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Polfa Tarchomin
Detailed financials for Polfa Tarchomin
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polfa Tarchomin Comparisons
Peer comparison for Polfa Tarchomin
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polfa Tarchomin
Polfa Tarchomin operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, NEUCA, Pelion and Vitama, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical distribution and supply chain services are provided globally.
|
|
| Locked | Locked | Locked |
Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland.
|
|
| Locked | Locked | Locked |
Pelion is recognized as a leading healthcare company in Poland.
|
|
| Locked | Locked | Locked |
Pharmaceutical products are distributed by Vitama in Poland.
|
Detailed competitors of Polfa Tarchomin
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polfa Tarchomin
Complete news archive for Polfa Tarchomin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polfa Tarchomin
Polfa Tarchomin was founded in 1823.
Polfa Tarchomin is headquartered in Warsaw, Poland.
Polfa Tarchomin, established in 1823, operates as a pharmaceutical company in Warsaw, Poland, producing generic drugs in areas like anti-infectives and metabolism. They manufacture active pharmaceutical ingredients and dietary supplements using multiple production lines. The company serves public healthcare systems, doctors, patients, and wholesalers through contract manufacturing and international exports, focusing on quality and innovation.
Polfa Tarchomin's top competitors include AmerisourceBergen, NEUCA and Pelion.
Polfa Tarchomin offers Dermocort Hydrocortisonum, MICONAL, OPTISTERIN, OSŁONIK MAX EXTRA, and 2 more products and services.